XSHE
002614
Market cap413mUSD
Jul 10, Last price
4.56CNY
1D
1.33%
1Q
-27.85%
Jan 2017
-65.82%
IPO
-53.15%
Name
Xiamen Comfort Science & Technology Group Co Ltd
Chart & Performance
P/E
231.72
P/S
0.56
EPS
0.02
Div Yield, %
2.22%
Shrs. gr., 5y
-1.86%
Rev. gr., 5y
-8.49%
Revenues
5.09b
+5.25%
Net income
12m
-80.89%
CFO
41m
-68.88%
Dividend
May 29, 20250.1 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in Xiamen, China, in 1996, the company initially known as Xiamen Comfort Science&Technology Group Co., Ltd rebranded to Ogawa Smart Healthcare Technology Group Co., Ltd in May 2017. This enterprise is dedicated to the research, development, manufacturing, and worldwide distribution of a diverse range of health and wellness products. Its extensive offerings include advanced massage solutions like chairs and other devices, environmental control equipment such as humidifiers, air purifiers, and fresh air systems, and a variety of home medical apparatus. This latter category encompasses blood pressure monitors, oximeters, laser hair removal devices, sports bracelets, and other personal health gadgets. These products are marketed predominantly under a portfolio of well-recognized brand names, including OGAWA, FUJI, FUJIMEDIC, COZZIA, MEDISANA, EASEWELL, ihoco, SHUSIJIA, and ETRO.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||